Eagle Asset Management Inc. trimmed its position in shares of Quidel Co. (NASDAQ:QDEL) by 8.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 582,792 shares of the company’s stock after selling 55,547 shares during the quarter. Eagle Asset Management Inc.’s holdings in Quidel were worth $35,754,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of QDEL. WINTON GROUP Ltd grew its holdings in Quidel by 74.9% during the 2nd quarter. WINTON GROUP Ltd now owns 10,592 shares of the company’s stock valued at $628,000 after purchasing an additional 4,537 shares during the last quarter. Bessemer Group Inc. grew its holdings in Quidel by 16.9% during the 2nd quarter. Bessemer Group Inc. now owns 9,000 shares of the company’s stock valued at $534,000 after purchasing an additional 1,300 shares during the last quarter. Rothschild & Co. Asset Management US Inc. grew its holdings in Quidel by 3.7% during the 2nd quarter. Rothschild & Co. Asset Management US Inc. now owns 472,419 shares of the company’s stock valued at $28,024,000 after purchasing an additional 16,966 shares during the last quarter. First Trust Advisors LP grew its holdings in Quidel by 65.9% during the 2nd quarter. First Trust Advisors LP now owns 60,741 shares of the company’s stock valued at $3,603,000 after purchasing an additional 24,132 shares during the last quarter. Finally, Janus Henderson Group PLC grew its holdings in Quidel by 74.4% during the 2nd quarter. Janus Henderson Group PLC now owns 18,960 shares of the company’s stock valued at $1,125,000 after purchasing an additional 8,087 shares during the last quarter. Institutional investors own 90.10% of the company’s stock.

A number of equities analysts have commented on the stock. TheStreet upgraded shares of Quidel from a “c+” rating to a “b” rating in a research note on Friday, November 1st. Zacks Investment Research upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research note on Friday. Craig Hallum upgraded shares of Quidel from a “hold” rating to a “buy” rating and upped their target price for the stock from $63.00 to $75.00 in a research note on Thursday, August 29th. Finally, ValuEngine upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $73.00.

In other Quidel news, CFO Randall J. Steward sold 29,328 shares of the firm’s stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $62.60, for a total value of $1,835,932.80. Following the completion of the transaction, the chief financial officer now owns 48,787 shares of the company’s stock, valued at $3,054,066.20. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Michael Donald Jr. Abney sold 8,798 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $65.00, for a total transaction of $571,870.00. Following the completion of the transaction, the senior vice president now directly owns 14,226 shares of the company’s stock, valued at approximately $924,690. The disclosure for this sale can be found here. In the last ninety days, insiders sold 118,361 shares of company stock valued at $312,782,451. Corporate insiders own 14.10% of the company’s stock.

Shares of QDEL stock opened at $59.55 on Friday. The company’s 50-day simple moving average is $59.97 and its two-hundred day simple moving average is $59.45. The company has a market capitalization of $2.58 billion, a P/E ratio of 21.12 and a beta of 1.41. Quidel Co. has a one year low of $44.27 and a one year high of $70.31. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 0.83.

Quidel (NASDAQ:QDEL) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.06. The business had revenue of $126.50 million during the quarter, compared to analysts’ expectations of $125.52 million. Quidel had a net margin of 14.51% and a return on equity of 22.48%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the company posted $0.59 earnings per share. On average, research analysts expect that Quidel Co. will post 2.55 EPS for the current fiscal year.

Quidel Company Profile

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.

Further Reading: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding QDEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quidel Co. (NASDAQ:QDEL).

Institutional Ownership by Quarter for Quidel (NASDAQ:QDEL)

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.